Results 21 to 30 of about 1,494,574 (301)

Interobserver variability and accuracy of p16/Ki-67 dual immunocytochemical staining on conventional cervical smears

Diagnostic Pathology, 2019
Background p16/Ki-67 dual immunocytochemical staining (DS) has been proven as a sensitive and specific test for triage of HPV positive women with good reproducibility and accuracy.
Veronika Kloboves Prevodnik, Tine Jerman, Nataša Nolde, Alenka Repše Fokter, Sandra Jezeršek, Živa Pohar Marinšek, Ulrika Klopčič, Simona Hutter Čelik, Kristina Gornik Kramberger, Maja Primic Žakelj, Urška Ivanuš   +10 more
doaj   +1 more source

Human papillomavirus infection in women undergoing in-vitro fertilization: effects on embryo development kinetics and live birth rate

Reproductive Biology and Endocrinology, 2023
Backgroud Several studies showed that human papillomavirus (HPV) affects male fertility, but its impact on female fertility and in vitro fertilization (IVF) outcome is not yet clear.
Federica Zullo, Valentina Fiano, Anna Gillio-Tos, Sara Leoncini, Ginevra Nesi, Luigia Macrì, Mario Preti, Alessandro Rolfo, Chiara Benedetto, Alberto Revelli, Laura De Marco   +10 more
doaj   +1 more source

Determinants of Acceptance of Cervical Cancer Screening in Dar es Salaam, Tanzania. [PDF]

, 2012
To describe how demographic characteristics and knowledge of cervical cancer influence screening acceptance among women living in Dar es Salaam, Tanzania. Multistage cluster sampling was carried out in 45 randomly selected streets in Dar es Salaam. Women
Dartell, Myassa Arkam, Kjaer, Susanne, Susanne Kjaer, Tersbol, Britt, Rasch, Vibeke, Kahesa, Crispin, Britt Tersbol, Kjaer, S., Dartell, M., Mwaiselage, Julius, Julius Mwaiselage, Ngoma, Twalib, Kahesa, C., Ngoma, T., Vibeke Rasch, Rasch, Vibeke; id_orcid, Twalib Ngoma, Dartell, Myassa, Mwaiselage, J., Crispin Kahesa, Myassa Dartell, Tersbol, B., Rasch, V.   +22 more
core   +2 more sources

Irish Cervical Screening Programme annual report 2005 [PDF]

, 2006
Irish Cervical Screening Programme ...
Irish Cervical Screening Programme (ICSP)
core   +1 more source

Knowledge on cervical cancer screening and vaccination among females at Oyibi Community

BMC Women's Health, 2021
Background Awareness about cervical cancer screening and vaccination in the developed countries are high as compared to the developing countries. Sixty to eighty percent (60–80%) of the women who develop cervical cancer in sub-Saharan Africa live in the ...
Evans Appiah Osei, Stella Appiah, Judith Elinam Gaogli, Ezekiel Oti-Boadi   +3 more
doaj   +1 more source

Visual techniques for cervical cancer screening in Colombia

Biomédica: revista del Instituto Nacional de Salud, 2019
Introduction: Direct visual inspection for cervical cancer screening remains controversial, whereas colposcopy-biopsy is considered the gold standard for diagnosis of preneoplastic cervical lesions.
Óscar Gamboa, Mauricio González, Jairo Bonilla, Joaquín Luna, Raul Murillo, Cervical Cancer Screening Study Group INC   +5 more
doaj   +1 more source

Cervical Cancer Screening [PDF]

JAMA, 2014
of the Clinical Problem Approximately 12 000 new cases of cervical cancer are expected to occur in the United States in 2014, with 4000 deaths from the disease.1 Women younger than 50 years have the highest incidenceofcervicalcancer,andthedisease ismoreprevalent inHispanic andblackwomen.
Anna, Volerman, Adam S, Cifu
openaire   +4 more sources

Clinical relevance of the borderline results of the Hybrid Capture 2 High-Risk HPV DNA assay with cervical samples collected in Specimen Transport Medium

Radiology and Oncology, 2019
The Hybrid Capture 2 (HC2) High-Risk HPV DNA assay serves as a triage test in the Slovenian national cervical cancer screening programme ZORA. To improve the limited analytical accuracy of HC2 test results near the cut-off value (1.0 relative light units/
Varl Jerneja, Ivanus Urska, Marinsek Ziva Pohar, Jerman Tine, Valencak Anja Ostrbenk, Poljak Mario, Prevodnik Veronika Kloboves   +6 more
doaj   +1 more source

Factors associated with late presentation of cervical cancer cases at a district hospital: a retrospective study

BMC Public Health, 2018
Background Cervical cancer is the leading and most common female cancer among women in Ghana. Although there are screening methods to detect premalignant lesions for treatment, screening coverage in Ghana is 2.8% and late presentation of cases ...
Priscilla Dunyo, Kofi Effah, Emilia Asuquo Udofia   +2 more
doaj   +1 more source

Factors explaining men’s intentions to support their partner’s participation in cervical cancer screening

BMC Women's Health, 2022
Background Cervical cancer represents a high burden of disease. Many women in low- and middle-income countries face opposition from their partners and families to undergo cervical cancer screening.
Jyoshma Preema Dsouza, Stephan Van den Broucke, Sanjay Pattanshetty, William Dhoore   +3 more
doaj   +1 more source